The prevalence of relevant drug-drug interactions and associated clinical outcomes in patients with cancer-associated thrombosis on concurrent anticoagulation and anticancer or supportive care therapies-Reference-Cited by-同舟云学术

The prevalence of relevant drug-drug interactions and associated clinical outcomes in patients with cancer-associated thrombosis on concurrent anticoagulation and anticancer or supportive care therapies

Published:2023-11 Issue: Volume:231 Page:128-134
ISSN:0049-3848
Container-title:Thrombosis Research
language:en
Short-container-title:Thrombosis Research

Author:

Wang Tzu-Fei,Hill Madeleine,Mallick Ranjeeta,Chaudry Hina,Unachukwu Ubabuko,Delluc Aurélien,Carrier Marc

Publisher

Elsevier BV

Subject

Hematology

Reference29 articles.

1. Venous thromboembolism in cancer patients: a population-based cohort study;Mulder;Blood,2021

2. Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy;Khorana;J. Thromb. Haemost.,2007

3. Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis;Prandoni;Blood,2002

4. Edoxaban for the treatment of cancer-associated venous thromboembolism;Raskob;N. Engl. J. Med.,2018

5. Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D);Young;J. Clin. Oncol.,2018

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Letter to the editor regarding the paper by A. Boileve et al.: Safety of direct oral anticoagulants in patients with advanced solid tumors receiving anti‑VEGF agents: a retrospective study;Supportive Care in Cancer;2024-09-10

2. Bleeding Risk in Patients with Cancer;Hämostaseologie;2024-09-03

3. Preventative and curative treatment of venous thromboembolic disease in cancer patients;La Presse Médicale;2024-09

4. Multiple drugs;Reactions Weekly;2024-04-06